Delivery Order SPE2DB22D3501-SPE2DB25FXG52
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,095.38 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL on August 15, 2025, with completion scheduled for August 18, 2025. The contract employs firm fixed pricing and was awarded without set-aside designation through competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,836.65 by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, for the supply of Norditropin Flexpro 10 mg/1.5 ml. This is a non-set-aside, competitively awarded contract with firm fixed pricing, with an ultimate completion date of August 29, 2025. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $3,700.78 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- AmerisourceBergen Drug Corp was awarded a $2,822.39 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 ml. The award is non-set-aside and represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. Performance will be completed by September 4, 2025, with services executed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, valued at $8,738.61. This non-set-aside competitive award is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,746.15 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml pharmaceutical product on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $4,198.91 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL medication, with performance to be completed by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,283.33 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,806.98 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $1,502.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Norditropin FlexPro 5 mg/1.5 mL medication. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by August 11, 2025, with performance...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXG52Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,912.70 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL injectables. This competitively awarded, firm fixed-price contract is scheduled for completion by September 12, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued without set-aside designation and represents a routine pharmaceutical procurement within the federal medical supply chain supporting military and defense healthcare requirements. This award is a child order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency, providing a wide range of brand-name and generic medications, vaccines, medical devices, and specialty pharmaceuticals to support military healthcare systems globally. The company's participation in the DLA Troop Support Medical supply chain positions it as a primary source for pharmaceutical commodities serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/11/25 |